Trexquant Investment LP - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q4 2022. The put-call ratio across all filers is 3.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2023$1,213,926
-66.8%
14,258
-67.7%
0.03%
-68.0%
Q1 2023$3,658,129
-28.6%
44,207
-32.1%
0.10%
-31.0%
Q4 2022$5,120,194
+380.3%
65,101
+352.2%
0.14%
+291.9%
Q3 2022$1,066,000
-87.1%
14,396
-88.6%
0.04%
-90.0%
Q2 2022$8,241,000
+3715.3%
126,439
+3604.6%
0.37%
+3590.0%
Q1 2022$216,000
-48.2%
3,413
-56.6%
0.01%
-61.5%
Q4 2021$417,000
+19.8%
7,869
+168.8%
0.03%
-29.7%
Q4 2020$348,000
-17.9%
2,928
-39.7%
0.04%
+37.0%
Q3 2020$424,000
-42.5%
4,857
-24.3%
0.03%
-38.6%
Q4 2019$737,000
-22.3%
6,417
-14.7%
0.04%
-46.3%
Q3 2019$949,000
-10.3%
7,526
-37.8%
0.08%
+9.3%
Q1 2019$1,058,000
+344.5%
12,093
+481.4%
0.08%
+316.7%
Q3 2018$238,000
-92.7%
2,080
-94.3%
0.02%
-92.0%
Q2 2018$3,261,000
+139.6%
36,365
+95.4%
0.23%
+137.9%
Q1 2018$1,361,000
+194.6%
18,609
+80.6%
0.10%
-18.1%
Q3 2017$462,000
+71.7%
10,302
+54.2%
0.12%
+169.8%
Q4 2016$269,000
-25.5%
6,682
-46.3%
0.04%
-8.5%
Q2 2016$361,000
-7.7%
12,445
+2.9%
0.05%
+38.2%
Q3 2015$391,00012,1000.03%
Other shareholders
HAEMONETICS CORP shareholders Q4 2022
NameSharesValueWeighting ↓
Millrace Asset Group, Inc. 19,264$1,7262.13%
Parkman Healthcare Partners LLC 88,962$7,969,2161.46%
HEARTLAND ADVISORS INC 256,414$24,435,2741.37%
Riverwater Partners LLC 15,553$1,393,2381.27%
KINGDON CAPITAL MANAGEMENT, L.L.C. 111,100$9,952,3381.15%
Lisanti Capital Growth, LLC 78,425$7,025,3121.11%
Aristotle Capital Boston, LLC 311,666$27,919,0540.90%
ROYCE & ASSOCIATES LP 947,550$84,881,5290.86%
CHASE INVESTMENT COUNSEL CORP 18,770$1,6810.84%
Virtus Investment Advisers, Inc. 13,662$1,223,8420.83%
View complete list of HAEMONETICS CORP shareholders